90 related articles for article (PubMed ID: 6164884)
1. Application of human leucocyte interferon in patients with tumours of the head and neck.
Ikić D; Padovan I; Brodarec I; Knezević M; Soos E
Lancet; 1981 May; 1(8228):1025-7. PubMed ID: 6164884
[TBL] [Abstract][Full Text] [Related]
2. Effect of interferon in therapy of skin and head and neck tumors.
Padovan I; Brodarec I; Ikić D; Knezević M; Soos E
J Cancer Res Clin Oncol; 1981; 100(3):295-310. PubMed ID: 6168641
[TBL] [Abstract][Full Text] [Related]
3. Application of human leucocyte interferon in patients with carcinoma of the uterine cervix.
Ikić D; Krusić J; Kirhmajer V; Knezević M; Maricić Z; Rode B; Jusić D; Soos E
Lancet; 1981 May; 1(8228):1027-30. PubMed ID: 6164885
[TBL] [Abstract][Full Text] [Related]
4. Application of human leucocyte interferon in patients with urinary bladder papillomatosis, breast cancer, and melanoma.
Ikić D; Nola P; Maricić Z; Smudj K; Oresić V; Knezević M; Rode B; Jusić D; Soos E
Lancet; 1981 May; 1(8228):1022-4. PubMed ID: 6164883
[TBL] [Abstract][Full Text] [Related]
5. Inferior outcomes in immunosuppressed patients with high-risk cutaneous squamous cell carcinoma of the head and neck treated with surgery and radiation therapy.
Manyam BV; Gastman B; Zhang AY; Reddy CA; Burkey BB; Scharpf J; Alam DS; Fritz MA; Vidimos AT; Koyfman SA
J Am Acad Dermatol; 2015 Aug; 73(2):221-7. PubMed ID: 26028524
[TBL] [Abstract][Full Text] [Related]
6. How we do it: Chemo-electroporation in the head and neck for otherwise untreatable patients.
Tijink BM; De Bree R; Van Dongen GA; Leemans CR
Clin Otolaryngol; 2006 Oct; 31(5):447-51. PubMed ID: 17014460
[TBL] [Abstract][Full Text] [Related]
7. Perineural infiltration by cutaneous squamous cell carcinomas of the head and neck.
Di Gregorio C; Gebbia V; Florena AM; Franco V; Moschella F
Anticancer Res; 1995; 15(3):1107-15. PubMed ID: 7645933
[TBL] [Abstract][Full Text] [Related]
8. Interferon therapy for basal cell carcinoma and squamous cell carcinoma.
Ikić D; Padovan I; Pipić N; Knezević M; Djaković N; Rode B; Kosutić I; Belicza M; Cajkovac V
Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):342-6. PubMed ID: 1937994
[TBL] [Abstract][Full Text] [Related]
9. Node-positive cutaneous squamous cell carcinoma of the head and neck: Survival, high-risk features, and adjuvant chemoradiotherapy outcomes.
Amoils M; Lee CS; Sunwoo J; Aasi SZ; Hara W; Kim J; Sirjani D; Colevas AD; Chang AL; Divi V
Head Neck; 2017 May; 39(5):881-885. PubMed ID: 28252823
[TBL] [Abstract][Full Text] [Related]
10. Direct skin involvement of cervical lymph node metastasis from mucosal squamous cell carcinoma of the head and neck.
Dragan AD; Nixon IJ; Orabi AA; Manganaris A; Jeannon JP; Guerrero-Urbano MT; Simo R
J Laryngol Otol; 2013 Feb; 127(2):181-6. PubMed ID: 23217250
[TBL] [Abstract][Full Text] [Related]
11. A multi-institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck.
Manyam BV; Garsa AA; Chin RI; Reddy CA; Gastman B; Thorstad W; Yom SS; Nussenbaum B; Wang SJ; Vidimos AT; Koyfman SA
Cancer; 2017 Jun; 123(11):2054-2060. PubMed ID: 28171708
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of disease-free interval in head and neck cutaneous squamous cell carcinoma with nodal metastases.
Ebrahimi A; Clark JR; Ahmadi N; Palme CE; Morgan GJ; Veness MJ
Head Neck; 2013 Aug; 35(8):1138-43. PubMed ID: 23152126
[TBL] [Abstract][Full Text] [Related]
13. Skin metastases from a head and neck carcinoma: a prognostic factor?
Dequanter D; Mboti FB; Lothaire P; Andry G
B-ENT; 2005; 1(3):113-5. PubMed ID: 16255495
[TBL] [Abstract][Full Text] [Related]
14. The role of intratumour therapy with electroporation and bleomycin in the management of advanced squamous cell carcinoma of the head and neck.
Bloom DC; Goldfarb PM
Eur J Surg Oncol; 2005 Nov; 31(9):1029-35. PubMed ID: 16150565
[TBL] [Abstract][Full Text] [Related]
15. The role of changes in maximum standardized uptake value of FDG PET-CT for post-treatment surveillance in patients with head and neck squamous cell carcinoma treated with chemoradiotherapy: preliminary findings.
Matoba M; Tuji H; Shimode Y; Kondo T; Oota K; Tonami H
Br J Radiol; 2017 Mar; 90(1071):20150404. PubMed ID: 28055245
[TBL] [Abstract][Full Text] [Related]
16. Histopathologic and histoenzymatic observations in carcinomas treated with human leukocyte interferon.
Knezević M; Rode B; Knezević-Krivak S; Ikić D; Maricić Z; Krusić J; Padovan I; Nola P; Brodarec I; Jusić D; Soos E
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):27-38. PubMed ID: 6173341
[TBL] [Abstract][Full Text] [Related]
17. Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.
Tanvetyanon T; Padhya T; McCaffrey J; Kish JA; Deconti RC; Trotti A; Rao NG
Head Neck; 2015 Jun; 37(6):840-5. PubMed ID: 24623654
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.
Hinerman RW; Indelicato DJ; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Kirwan J; Mendenhall WM
Laryngoscope; 2008 Nov; 118(11):1989-96. PubMed ID: 18849863
[TBL] [Abstract][Full Text] [Related]
19. A New Approach to Survival Analysis of Head and Neck Squamous Cell Carcinoma.
Masoudi S; Montazeri SA; Pourdanesh F; Biglarian A; Kazemi M; Rahgozar M
Arch Iran Med; 2017 Aug; 20(8):503-510. PubMed ID: 28846014
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma of the head and neck. Selective management according to site and stage--skin.
Levine HL; Ratz JL; Bailin P
Otolaryngol Clin North Am; 1985 Aug; 18(3):499-503. PubMed ID: 4047671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
